Volume 3, Issue 1 (7-2005)                   IJRM 2005, 3(1): 9-13 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Omrani M D, Nordenskhold A. Mutation detection in human estrogen receptor ? gene in infertile male patients by denaturing high-performance liquid chromatography. IJRM. 2005; 3 (1) :9-13
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-33-en.html
Abstract:   (1213 Views)
Background: For screening sequence variations in genes, rapid turnover time is of fundamental importance. While, many of the current methods are unfortunately time consuming and technically difficult to implement. Denaturing high-performance liquid chromatography (DHPLC) method had been shown to be a high-throughput, time saving, and economical tool for mutation screening. Objective: In the present study DHPLC method was used to explore the potential association between estrogen receptor ? gene (ESR2) variants and male infertility. Materials and Methods: DNA from 96 men with infertility and 96 normal male as control were screened for mutation in the nine exons of the ESR2 gene, using WAVE� DHPLC device equipped with a DNA separation column and automated sequence analysis on the ABI Prism 310. Results: DHPLC evaluation of ESR2 gene in 96 infertile patients, revealed one heterozygous sequence variation (IVS 8�4G>A) near the 5� splicing region of intron 8 in 5 patients. No variation was identified in control population. Conclusion: Mutation detection by DHPLC, as it is presented in this context, is a high-throughput, quick, and economical tool for mutation screening. The gene alterations in ESR2 gene that we�ve found might increase susceptibility to infertility; but without cDNA screening, the consequences of these genetic alterations cannot be predicted
Full-Text [PDF 113 kb]   (176 Downloads) |   |   Full-Text (HTML)  (76 Views)  
Type of Study: Original Article |

References
1. Le Marechal C, Audrezet MP, Quere I, Raguenes O, Langonne S, Ferec C. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (DHPLC): major implications for genetic counselling. Hum Genet 2001; 108: 290-298. [DOI:10.1007/s004390100490] [PMID]
2. Roberts PS, Jozwiak S, Kwiatkowski DJ, Dabora SL. Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene. J Biochem Biophys Methods 2001; 47: 33-37. [DOI:10.1016/S0165-022X(00)00149-4]
3. Holinski-Feder E, Muller-Koch Y, Friedl W, Moeslein G, Keller G, Plaschke J, et al. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods 2001; 47: 21-32. [DOI:10.1016/S0165-022X(00)00148-2]
4. Kaler SG, Devaney JM, Pettit EL, Kirshman R, Marino MA. Novel method for molecular detection of the two common hereditary hemochromatosis mutations. Genet Test 2000; 4: 125-129. [DOI:10.1089/10906570050114821] [PMID]
5. O'Donovan MC, Oefner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy C, et al. Upadhyaya M, Sommer SS, McGuffin P. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 1998; 52: 4-49. [DOI:10.1006/geno.1998.5411] [PMID]
6. Wagner TM, Moslinger RA, Muhr D, Langbauer G, Hirtenlehner K, Concin H, et al. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer 1998; 77: 354-360. https://doi.org/10.1002/(SICI)1097-0215(19980729)77:3<354::AID-IJC8>3.0.CO;2-N [DOI:10.1002/(SICI)1097-0215(19980729)77:33.0.CO;2-N]
7. Wagner TM, Hirtenlehner K, Shen P, Moeslinger R, Muhr D, Fleischmann E, et al. Lobal sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet 1999; 8: 413-423. [DOI:10.1093/hmg/8.3.413] [PMID]
8. Underhill PA, Jin L, Lin AA . Detection of numerous Y chromosome bialleleic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 1997; 7: 996-1005. [DOI:10.1101/gr.7.10.996] [PMID] [PMCID]
9. Kuklin A, Munson K, Gjerde D, Haefele R, Taylor P. Detection of single-nucleotide polymorphisms with the WAVETM DNA Fragment Analysis System. Genet Test 1997; 1: 201-206. [DOI:10.1089/gte.1997.1.201] [PMID]
10. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN, James DC. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 1998; 26: 1396-1400. [DOI:10.1093/nar/26.6.1396] [PMID] [PMCID]
11. Choy YS, Dabora SL, Hall F, Ramesh V, Niida Y, Franz D, et al. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet 1999; 63: 383-391. [DOI:10.1046/j.1469-1809.1999.6350383.x] [PMID]
12. Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Gene 1999; 105: 72-78. [DOI:10.1007/s004399900092] [PMID]
13. Wagner T, Stoppa-Lyonnet D, Fleischmann E.Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 1999; 62: 369-376. [DOI:10.1006/geno.1999.6026] [PMID]
14. Carreau S, Lambard S, Delalande C, Denis-Galeraud I, Bilinska B, Bourguiba S. Aromatase expression and role of estrogens in male gonad. Rev Reprod Bio and Endo 2003; 1:35. [DOI:10.1186/1477-7827-1-35] [PMID] [PMCID]
15. Westberg L, Baghaei F, Rosmond R, Hellstrand M, Landén M, Jansson M, et al. Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor ß Gene Are Associated with Androgen Levels in Women. J Clin Endocrinol Metab 2001; 86(6): 2562-2568. [DOI:10.1210/jc.86.6.2562]
16. Kong EH, Pike AC, Hubbard RE. Structure and mechanism of the estrogen receptor. Biochem Soc Trans 2003; 31(1): 56-59. [DOI:10.1042/bst0310056] [PMID]
17. Barkhem T, Nilsson S, Gustafsson JA. Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action. Am J Pharmacogenomics 2004; 4(1): 19-28. [DOI:10.2165/00129785-200404010-00003] [PMID]
18. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 592-593. [DOI:10.1073/pnas.93.12.5925] [PMID] [PMCID]
19. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997; 82 (12): 4258-4265. [DOI:10.1210/jcem.82.12.4470] [PMID]
20. Gruber CJ, Gruber DM, Gruber IML, Wieser F, Huber JC. Anatomy of the estrogen response element. Trends Endocrinol Metab 2004; 15 (2): 73-78. [DOI:10.1016/j.tem.2004.01.008] [PMID]
21. Warner M, and Gustafsson JA. How to understand estrogen signaling from the phenotypes of ERalpha and ERbeta knockout mice. Ernst Schering Res Found Workshop 2004; 46: 63-77. [DOI:10.1007/978-3-662-05386-7_5] [PMID]
22. Nilsson M, Dahlman-Wright K, Gustafsson JA. Nuclear receptors in disease: the oestrogen receptors. Essays Biochem 2004; 40: 157-167. [DOI:10.1042/bse0400157] [PMID]
23. Chieffi P, Colucci D'Amato L, Guarino F, Salvatore G, Angelini F. 17-estradiol induces spermatogonial proliferation through mitogen-activated protein kinase (extracellular signal-regulated kinase 1/2) activity in the lizard (Podarcis s. sicula), Mol Reprod Dev 2002; 61(2) 218-225. [DOI:10.1002/mrd.1151] [PMID]
24. Elaine CM, Alba MS, Fabiane PT, Francisco JB, Sampaio CFR. Effects of Malnutrition in the Testis. Braz J Urol 2001; 27: 500-506.
25. Scariano JK, Simplicio SG, Montoya GD, Garry PJ, Baumgartner RN. Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int 2004; 74(6): 501-508. [DOI:10.1007/s00223-003-0170-x] [PMID]
26. Shearman AM, Karasik D, Gruenthal KM, Demissie S, Cupples LA, Housman DE, et al. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the Framingham Study. J Bone Miner Res 2004; 19(5): 773-781. [DOI:10.1359/jbmr.0301258] [PMID]
27. Lau EM, Young RP, Lam V. Estrogen receptor beta gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women. Bone 2002; 31(2): 276-281. [DOI:10.1016/S8756-3282(02)00827-X]
28. Ogawa S, Hosoi T, Shiraki M, Orimo H, Emi M, Muramatsu M, et al. Association of estrogen receptor beta gene polymorphism with bone mineral density. Biochem Biophys Res Commun 2000; 16; 269(2): 537-541. [DOI:10.1006/bbrc.2000.2285] [PMID]
29. Setiawan VW, Hankinson S, Colditz G, Hunter D, Vivo ID. Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States). Cancer Causes Control 2004; 15(6): 627-633. [DOI:10.1023/B:CACO.0000036170.28502.5f] [PMID]
30. Ogawa S, Emi M, Shiraki M, Hosoi T, Ouchi Y, Inoue S. Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure. J Hum Genet 2000; 45(6):327-330. [DOI:10.1007/s100380070002] [PMID]
31. Tazuke S, Khaw KT, Barrett-Connor E. Exogenous estrogen and endogenous sex hormones. Medicine1992; 71: 44-51. [DOI:10.1097/00005792-199201000-00004] [PMID]
32. Casson PR , Elkind-Hirsch, KE , Buster JE, Hornsby PJ, Carson SA, Snabes MC. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997; 90: 995-998. [DOI:10.1016/S0029-7844(97)00538-3]
33. Carr BR, Breslau NA, Givens C, Byrd W, Barnett-Hamm C, Marshburn PB. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study. J Clin Endocrinol Metab 1995; 80: 1169 -1178. [DOI:10.1210/jcem.80.4.7714086] [PMID]

© 2021 CC BY-NC 4.0 | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb